Abstract:Pathogenic variants in the SYNE1 gene are associated with a phenotypic spectrum spanning from late-onset, slowly progressive, relatively pure ataxia to early-onset, fast progressive multisystemic disease. Since its first description in 2007 as an adult-onset ataxia in French Canadian families, subsequent identification of patients worldwide has widened the clinical spectrum and increased the number of identified pathogenic variants. We report a 20-year-old Faroese female with early-onset progressive gait problems, weakness, dysphagia, slurred speech, orthostatic dizziness, and urge incontinence. Neurological examination revealed mild cognitive deficits, dysarthria, broken slow pursuit, hypometric saccades, weakness with spasticity, hyperreflexia, absent ankle reflexes, ataxia, and wide-based, spastic gait. Magnetic resonance imaging displayed atrophy of the cerebellum, brainstem, and spinal cord. Severely prolonged central motor conduction time and lower motor neuron involvement was demonstrated electrophysiologically. Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan showed hypometabolism of the cerebellum and right frontal lobe. Muscle biopsy revealed chronic neurogenic changes and near-absent immunostaining for Nesprin-1. Next-generation sequencing revealed a previously undescribed homozygous truncating, likely pathogenic variant in the SYNE1 gene. The patient's mother and paternal grandfather were heterozygous carriers of the variant. Her father's genotype was unobtainable. We expand the list of likely pathogenic variants in SYNE1 ataxia with a novel homozygous truncating variant with proximity to the C-terminus and relate it to a phenotype comprising early-onset cerebellar deficits, upper and lower motor neuron involvement and cognitive deficits. Also, we report novel findings of focally reduced frontal lobe FDG-PET uptake and motor evoked potential abnormalities suggestive of central demyelination.

SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene

Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: Expanding the phenotype

Research on gene mutation and clinical characteristics of hereditary spinocerebellar ataxia type 6 from 2 Chinese families

A Familial Late-Onset Hereditary Ataxia Mimicking Pontocerebellar Hypoplasia Caused by A Novel Tsen54 Mutation

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

Comparison of two families with and without ataxia harboring novel variants in PRKCG

Novel mutation in exon11 of PRKCG (SCA14): A case report

Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14

Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus

Autosomal dominant cerebellar ataxias: new genes and progress towards treatments

Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)

Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report

Novel Homozygous Truncating Variant Widens the Spectrum of Early-Onset Multisystemic SYNE1 Ataxia

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

Clinical Characteristics, Radiological Features and Gene Mutation in 10 Chinese Families with Spinocerebellar Ataxias

Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy

Identification and characterisation of pathogenic and non-pathogenic FGF14 repeat expansions

Genetic Profile And Clinical Characteristics Of Chinese Patients With Spinocerebellar Ataxia Type 2: A Multicenter Experience Over 10 Years

Widening the spectrum of spinocerebellar ataxia autosomal recessive type 10 (SCAR10)

Neuroradiological findings in GAA-FGF14 ataxia (SCA27B): more than cerebellar atrophy.